Understanding Myeloproliferative Disorders

Understanding Supportive Care: Terms and Resources to Know

Expert Dr. Ishwaria Subbiah explains what tools are available to help support patients on their treatment journey, from body pain and symptom management to spiritual and emotional distress.

Published:

Progression in MPNs: Allaying Fears and Taking Action

In part two of our Partners series, leading expert Dr. Mark Heaney and MPN patients Ann and Jonna discuss risk stratification, progression, potential complications and actionable steps to take to access the best care available.

Published:

Experts Explain: Tools for Determining Prognosis With Myelofibrosis

Many MPN patients want to know how their disease will change over time and what factors indicate progression. What risk assessment tools are used by the experts? Watch now to find out.

Published:

Does the Clinical Trial Process Need an Extreme Makeover?

In this MythBusters program, patient advocate Jim Omel and Dr. Michael Thompson examine barriers patients may face and discuss the safety and quality of clinical trial care. Does the process need a makeover? Watch now to find out more.

Published:

Regulating the Course of MPNs: What Are Inhibitors and How Do They Work?

Can modern MPN treatments disrupt the abnormal molecular signaling in cancerous cells? A panel of MPN experts discuss pathway inhibitors and their effect on proliferative activity and disease course. Watch now to learn more.

Published:

The Clinical Trial Process: An Explanation of How Efficacy and Patient Safety Are Monitored

A panel of experts explain the layers of review, or clinical trial phases, that go into the development of new therapies. How are MPN patients protected throughout the process? Watch now to also learn about safeguards in place before and during the study.

Published:

Understanding MPNs: Experts Explain Essential Thrombocythemia, Myelofibrosis and Polycythemia Vera

MPN experts, Lindsey Lyle and Dr. Brandon McMahon, explain how ET, MF and PV manifest in the body, distinguishing features of each disease, key indicators doctors look for upon diagnosis, and more. Watch now to learn about the characteristics of MPNs.

Published:

Determining Risk: What Testing and Genetic Mutations Reveal About Your MPN

Dr. Naval Daver gives expert insight into getting a definitive MPN diagnosis, distinguishing between ET, PV and MF, and the role of genetic mutations in diagnostics, progression and finding an effective treatment plan.

Published:

The Value in Seeing an MPN Specialist: Devising a Plan for Treatment and Follow-Up

From our first “Partners” program in the series, geared towards newly diagnosed MPN patients, a clinician and patients share their perspective on consultations with specialists and seeking a second opinion.

Published:

Showing 9 of 303 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on November 7, 2013